(Q44015267)

English

Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat.

scientific article published in May 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Mark A Prendergast

5

object named as

Mark A Prendergast

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Sveta Mayer

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Barton Harris

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

D Alex Gibson

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

John Blanchard

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Robert C Holley

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

John Littleton

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

655-662

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Acamprosate inhibits Ca2+ influx mediated by NMDA receptors and voltage-sensitive Ca2+ channels in cultured rat mesencephalic neurones.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Development of kainic acid and N-methyl-D-aspartic acid toxicity in organotypic hippocampal cultures.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

MK-801-induced neuronal damage in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Characteristics of protective effects of NMDA antagonist and calcium channel antagonist on ischemic calcium accumulation in rat hippocampal CA1 region

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Polyamines modulate the neurotoxic effects of NMDA in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

L-homocysteic acid: an endogenous excitotoxic ligand of the NMDA receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

In vitro effects of ethanol withdrawal and spermidine on viability of hippocampus from male and female rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Clinical pharmacokinetics of acamprosate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

A simple method for organotypic cultures of nervous tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2002.TB02587.X

21 January 2018

Identifiers

10.1111/J.1530-0277.2002.TB02587.X

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44015267&oldid=2105650707"